SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6anv'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E06_A_IPBA600_0 (ODORANT-BINDING PROTEIN)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 6	VAL A 88 VAL A 130 ILE A 140 ASN A 347	None	0.93A	1e06A-6anvA: undetectable	1e06A-6anvA: 17.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FDU_D_ESTD352_1 (17-BETA-HYDROXYSTERO ID DEHYDROGENASE)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 6	SER A 38 VAL A 39 GLY A 40 GLU A 66	None None MES A 502 (-3.4A) None	0.86A	1fduD-6anvA: undetectable	1fduD-6anvA: 19.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KGL_A_RTLA175_1 (CELLULAR RETINOL-BINDING PROTEIN TYPE I)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 7	LEU A 384 ILE A 409 THR A 173 MET A 401	None	1.16A	1kglA-6anvA: undetectable	1kglA-6anvA: 13.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VE3_A_REAA1445_1 (PUTATIVE CYTOCHROME P450 120)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	5 / 12	ALA A 344 LEU A 360 PHE A 359 VAL A 373 GLY A 96	None	1.08A	2ve3A-6anvA: undetectable	2ve3A-6anvA: 23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W98_A_P1ZA1352_1 (PROSTAGLANDIN REDUCTASE 2)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 7	TYR A 55 LEU A 7 ASN A 16 LYS A 5	None	1.44A	2w98A-6anvA: undetectable 2w98B-6anvA: undetectable	2w98A-6anvA: 20.52 2w98B-6anvA: 20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZW9_A_SAMA801_1 (LEUCINE CARBOXYL METHYLTRANSFERASE 2)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 8	THR A 173 LEU A 365 ASP A 367 GLU A 191	None None None MTT A 501 (-2.7A)	1.04A	2zw9A-6anvA: undetectable	2zw9A-6anvA: 20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BGD_A_PM6A301_1 (THIOPURINE S-METHYLTRANSFERASE)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 6	PHE A 338 ALA A 242 LEU A 327 PRO A 239	None	1.00A	3bgdA-6anvA: undetectable	3bgdA-6anvA: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_C_SVRC507_1 (PHOSPHOLIPASE A2)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 7	VAL A 190 GLY A 380 PRO A 309 LYS A 385	None	0.77A	3bjwC-6anvA: undetectable	3bjwC-6anvA: 13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_G_SVRG506_1 (PHOSPHOLIPASE A2)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 8	VAL A 190 GLY A 380 PRO A 309 LYS A 385	None	0.92A	3bjwA-6anvA: undetectable	3bjwA-6anvA: 13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G2O_A_SAMA500_1 (PCZA361.24)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	3 / 3	ARG A 75 GLU A 118 ASP A 138	None	0.90A	3g2oA-6anvA: undetectable	3g2oA-6anvA: 21.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	12 / 12	ASP A 94 LYS A 95 LYS A 122 GLU A 124 GLU A 125 ALA A 143 ASP A 145 ARG A 146 GLU A 191 PRO A 234 TRP A 310 TYR A 421	MTT A 501 ( 3.0A) MTT A 501 (-2.7A) MES A 502 (-3.7A) MTT A 501 (-3.1A) MTT A 501 (-3.5A) MTT A 501 (-3.2A) MTT A 501 (-2.9A) MTT A 501 (-4.0A) MTT A 501 (-2.7A) MTT A 501 (-3.4A) MTT A 501 (-4.3A) MTT A 501 (-4.5A)	0.23A	3jyrA-6anvA: 62.4	3jyrA-6anvA: 80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	7 / 7	ASN A 92 TRP A 142 GLU A 233 TYR A 235 MET A 410 TRP A 420 ARG A 424	MTT A 501 (-4.6A) MTT A 501 (-4.1A) MTT A 501 (-3.2A) MTT A 501 (-3.8A) MTT A 501 ( 4.1A) MTT A 501 (-3.8A) MTT A 501 (-4.1A)	0.45A	3jyrA-6anvA: 62.4	3jyrA-6anvA: 80.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_V_BO2V1401_1 (PROTEASOME COMPONENT PUP1 PROTEASOME COMPONENT PUP3)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	5 / 11	GLN A 445 ALA A 444 ALA A 242 GLY A 246 ALA A 268	None	0.99A	3mg0V-6anvA: undetectable 3mg0W-6anvA: undetectable	3mg0V-6anvA: 21.68 3mg0W-6anvA: 17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N8Y_B_DIFB585_1 (PROSTAGLANDIN G/H SYNTHASE 1)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	5 / 12	VAL A 276 LEU A 240 GLY A 267 ALA A 268 LEU A 441	None	0.99A	3n8yB-6anvA: undetectable	3n8yB-6anvA: 20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R9T_C_BEZC264_0 (ECHA1_1)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 5	ALA A 41 GLU A 31 ALA A 18 MET A 1	MES A 502 (-4.6A) None None PEG A 509 ( 4.2A)	1.29A	3r9tC-6anvA: undetectable	3r9tC-6anvA: 20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SJ4_X_DXCX75_0 (CYTOCHROME C7)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	5 / 9	ILE A 212 LEU A 278 LYS A 336 ILE A 306 GLY A 271	None	1.26A	3sj4X-6anvA: undetectable	3sj4X-6anvA: 10.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	5 / 12	PHE A 236 GLY A 380 LEU A 379 GLU A 191 ALA A 311	MTT A 501 (-4.8A) None None MTT A 501 (-2.7A) None	0.82A	3tbgB-6anvA: undetectable	3tbgB-6anvA: 19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	5 / 12	PHE A 236 GLY A 380 LEU A 379 GLU A 191 ALA A 311	MTT A 501 (-4.8A) None None MTT A 501 (-2.7A) None	0.80A	3tbgD-6anvA: undetectable	3tbgD-6anvA: 19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWQ_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	5 / 12	ALA A 311 TYR A 97 TYR A 290 ASN A 314 GLY A 308	None None PEG A 509 (-3.6A) PEG A 509 (-4.0A) None	1.35A	3vwqA-6anvA: undetectable	3vwqA-6anvA: 20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VYW_A_SAMA501_1 (MNMC2)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 6	GLU A 388 ASP A 394 ASP A 367 ASN A 374	None	1.34A	3vywA-6anvA: undetectable	3vywA-6anvA: 22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VYW_D_SAMD401_1 (MNMC2)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 5	GLU A 388 ASP A 394 ASP A 367 ASN A 374	None	1.34A	3vywD-6anvA: undetectable	3vywD-6anvA: 22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4M2X_G_TMQG202_1 (DIHYDROFOLATE REDUCTASE)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	5 / 12	ILE A 346 ALA A 185 LEU A 100 VAL A 103 ILE A 139	None	1.08A	4m2xG-6anvA: undetectable	4m2xG-6anvA: 15.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 5	ASN A 347 ALA A 131 GLY A 136 ASP A 94	None None None MTT A 501 ( 3.0A)	1.00A	4n48A-6anvA: undetectable	4n48A-6anvA: 22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OR0_B_NPSB602_1 (SERUM ALBUMIN)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	5 / 9	ALA A 344 ALA A 185 LEU A 183 LEU A 342 VAL A 341	None	1.17A	4or0B-6anvA: undetectable	4or0B-6anvA: 22.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LJE_A_RTLA201_1 (RETINOL-BINDING PROTEIN 1)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	4 / 6	LEU A 384 ILE A 409 THR A 173 MET A 401	None	1.19A	5ljeA-6anvA: undetectable	5ljeA-6anvA: 13.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VOP_B_C2FB3001_1 (5-METHYLTETRAHYDROFO LATE HOMOCYSTEINE S-METHYLTRANSFERASE)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	3 / 3	ASP A 376 ASN A 98 ASP A 43	None PGE A 503 (-4.3A) PGE A 503 ( 4.4A)	0.90A	5vopB-6anvA: undetectable	5vopB-6anvA: 22.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_A_RBFA502_1 (RIBOFLAVIN LYASE)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	6 / 12	ALA A 422 ALA A 418 GLY A 246 ALA A 268 PHE A 249 VAL A 261	None	1.44A	5w4zA-6anvA: undetectable	5w4zA-6anvA: 11.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W4Z_B_RBFB502_1 (RIBOFLAVIN LYASE)	6anv	ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG (Escherichia coli; Pseudomonas phage JBD30)	6 / 12	ALA A 422 ALA A 418 GLY A 246 ALA A 268 PHE A 249 VAL A 261	None	1.46A	5w4zB-6anvA: undetectable	5w4zB-6anvA: 11.82

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1E06_A_IPBA600_0","ODORANT-BINDING PROTEIN","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"VAL A  88;VAL A 130;ILE A 140;ASN A 347","None","0.93A","1e06A-6anvA:undetectable","1e06A-6anvA:17.48"],["1FDU_D_ESTD352_1","17-BETA-HYDROXYSTEROID DEHYDROGENASE","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"SER A  38;VAL A  39;GLY A  40;GLU A  66","None;None;MES A 502 (-3.4A);None","0.86A","1fduD-6anvA:undetectable","1fduD-6anvA:19.23"],["1KGL_A_RTLA175_1","CELLULAR RETINOL-BINDING PROTEIN TYPE I","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"LEU A 384;ILE A 409;THR A 173;MET A 401","None","1.16A","1kglA-6anvA:undetectable","1kglA-6anvA:13.46"],["2VE3_A_REAA1445_1","PUTATIVE CYTOCHROME P450 120","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",5,"ALA A 344;LEU A 360;PHE A 359;VAL A 373;GLY A  96","None","1.08A","2ve3A-6anvA:undetectable","2ve3A-6anvA:23.20"],["2W98_A_P1ZA1352_1","PROSTAGLANDIN REDUCTASE 2;PROSTAGLANDIN REDUCTASE 2","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"TYR A  55;LEU A   7;ASN A  16;LYS A   5","None","1.44A","2w98A-6anvA:undetectable;2w98B-6anvA:undetectable","2w98A-6anvA:20.52;2w98B-6anvA:20.52"],["2ZW9_A_SAMA801_1","LEUCINE CARBOXYL METHYLTRANSFERASE 2","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"THR A 173;LEU A 365;ASP A 367;GLU A 191","None;None;None;MTT A 501 (-2.7A)","1.04A","2zw9A-6anvA:undetectable","2zw9A-6anvA:20.09"],["3BGD_A_PM6A301_1","THIOPURINE S-METHYLTRANSFERASE","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"PHE A 338;ALA A 242;LEU A 327;PRO A 239","None","1.00A","3bgdA-6anvA:undetectable","3bgdA-6anvA:21.10"],["3BJW_C_SVRC507_1","PHOSPHOLIPASE A2","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"VAL A 190;GLY A 380;PRO A 309;LYS A 385","None","0.77A","3bjwC-6anvA:undetectable","3bjwC-6anvA:13.71"],["3BJW_G_SVRG506_1","PHOSPHOLIPASE A2;PHOSPHOLIPASE A2","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"VAL A 190;GLY A 380;PRO A 309;LYS A 385","None","0.92A","3bjwA-6anvA:undetectable","3bjwA-6anvA:13.71"],["3G2O_A_SAMA500_1","PCZA361.24","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",3,"ARG A  75;GLU A 118;ASP A 138","None","0.90A","3g2oA-6anvA:undetectable","3g2oA-6anvA:21.30"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",12,"ASP A  94;LYS A  95;LYS A 122;GLU A 124;GLU A 125;ALA A 143;ASP A 145;ARG A 146;GLU A 191;PRO A 234;TRP A 310;TYR A 421","MTT A 501 ( 3.0A);MTT A 501 (-2.7A);MES A 502 (-3.7A);MTT A 501 (-3.1A);MTT A 501 (-3.5A);MTT A 501 (-3.2A);MTT A 501 (-2.9A);MTT A 501 (-4.0A);MTT A 501 (-2.7A);MTT A 501 (-3.4A);MTT A 501 (-4.3A);MTT A 501 (-4.5A)","0.23A","3jyrA-6anvA:62.4","3jyrA-6anvA:80.00"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",7,"ASN A  92;TRP A 142;GLU A 233;TYR A 235;MET A 410;TRP A 420;ARG A 424","MTT A 501 (-4.6A);MTT A 501 (-4.1A);MTT A 501 (-3.2A);MTT A 501 (-3.8A);MTT A 501 ( 4.1A);MTT A 501 (-3.8A);MTT A 501 (-4.1A)","0.45A","3jyrA-6anvA:62.4","3jyrA-6anvA:80.00"],["3MG0_V_BO2V1401_1","PROTEASOME COMPONENT PUP1;PROTEASOME COMPONENT PUP3","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",5,"GLN A 445;ALA A 444;ALA A 242;GLY A 246;ALA A 268","None","0.99A","3mg0V-6anvA:undetectable;3mg0W-6anvA:undetectable","3mg0V-6anvA:21.68;3mg0W-6anvA:17.79"],["3N8Y_B_DIFB585_1","PROSTAGLANDIN G\/H SYNTHASE 1","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",5,"VAL A 276;LEU A 240;GLY A 267;ALA A 268;LEU A 441","None","0.99A","3n8yB-6anvA:undetectable","3n8yB-6anvA:20.38"],["3R9T_C_BEZC264_0","ECHA1_1","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"ALA A  41;GLU A  31;ALA A  18;MET A   1","MES A 502 (-4.6A);None;None;PEG A 509 ( 4.2A)","1.29A","3r9tC-6anvA:undetectable","3r9tC-6anvA:20.95"],["3SJ4_X_DXCX75_0","CYTOCHROME C7","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",5,"ILE A 212;LEU A 278;LYS A 336;ILE A 306;GLY A 271","None","1.26A","3sj4X-6anvA:undetectable","3sj4X-6anvA:10.60"],["3TBG_B_RTZB1_1","CYTOCHROME P450 2D6","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",5,"PHE A 236;GLY A 380;LEU A 379;GLU A 191;ALA A 311","MTT A 501 (-4.8A);None;None;MTT A 501 (-2.7A);None","0.82A","3tbgB-6anvA:undetectable","3tbgB-6anvA:19.80"],["3TBG_D_RTZD1_1","CYTOCHROME P450 2D6","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",5,"PHE A 236;GLY A 380;LEU A 379;GLU A 191;ALA A 311","MTT A 501 (-4.8A);None;None;MTT A 501 (-2.7A);None","0.80A","3tbgD-6anvA:undetectable","3tbgD-6anvA:19.80"],["3VWQ_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",5,"ALA A 311;TYR A  97;TYR A 290;ASN A 314;GLY A 308","None;None;PEG A 509 (-3.6A);PEG A 509 (-4.0A);None","1.35A","3vwqA-6anvA:undetectable","3vwqA-6anvA:20.92"],["3VYW_A_SAMA501_1","MNMC2","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"GLU A 388;ASP A 394;ASP A 367;ASN A 374","None","1.34A","3vywA-6anvA:undetectable","3vywA-6anvA:22.08"],["3VYW_D_SAMD401_1","MNMC2","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"GLU A 388;ASP A 394;ASP A 367;ASN A 374","None","1.34A","3vywD-6anvA:undetectable","3vywD-6anvA:22.08"],["4M2X_G_TMQG202_1","DIHYDROFOLATE REDUCTASE","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",5,"ILE A 346;ALA A 185;LEU A 100;VAL A 103;ILE A 139","None","1.08A","4m2xG-6anvA:undetectable","4m2xG-6anvA:15.89"],["4N48_A_SAMA601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"ASN A 347;ALA A 131;GLY A 136;ASP A  94","None;None;None;MTT A 501 ( 3.0A)","1.00A","4n48A-6anvA:undetectable","4n48A-6anvA:22.14"],["4OR0_B_NPSB602_1","SERUM ALBUMIN","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",5,"ALA A 344;ALA A 185;LEU A 183;LEU A 342;VAL A 341","None","1.17A","4or0B-6anvA:undetectable","4or0B-6anvA:22.59"],["5LJE_A_RTLA201_1","RETINOL-BINDING PROTEIN 1","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",4,"LEU A 384;ILE A 409;THR A 173;MET A 401","None","1.19A","5ljeA-6anvA:undetectable","5ljeA-6anvA:13.17"],["5VOP_B_C2FB3001_1","5-METHYLTETRAHYDROFOLATE HOMOCYSTEINE S-METHYLTRANSFERASE","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",3,"ASP A 376;ASN A  98;ASP A  43","None;PGE A 503 (-4.3A);PGE A 503 ( 4.4A)","0.90A","5vopB-6anvA:undetectable","5vopB-6anvA:22.53"],["5W4Z_A_RBFA502_1","RIBOFLAVIN LYASE","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",6,"ALA A 422;ALA A 418;GLY A 246;ALA A 268;PHE A 249;VAL A 261","None","1.44A","5w4zA-6anvA:undetectable","5w4zA-6anvA:11.82"],["5W4Z_B_RBFB502_1","RIBOFLAVIN LYASE","6anv","ANTI-CRISPR PROTEIN ACRF1 FUSED WITH C-TERMINAL MBP TAG","Escherichia coli;Pseudomonas phage JBD30",6,"ALA A 422;ALA A 418;GLY A 246;ALA A 268;PHE A 249;VAL A 261","None","1.46A","5w4zB-6anvA:undetectable","5w4zB-6anvA:11.82"]]